Related Experiment Videos
The Associations Between Dietary Flavonoid Intake and Neurodegenerative Diseases Risk: A Cross-Sectional Study.
Chenzhong Zong1, Yang Dong2, Xue Yu3
1School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Chemical Biology & Drug Design
|June 24, 2026
Summary
Higher dietary intake of flavonoids, especially flavones and flavonols, is linked to a reduced risk of neurodegenerative diseases (NDs). Moderate consumption may offer protective benefits against conditions like Alzheimer's and Parkinson's disease.
Area of Science:
- Nutrition Science
- Neuroscience
- Epidemiology
Background:
- Neurodegenerative diseases (NDs), including Alzheimer's and Parkinson's, represent a growing global health concern.
- Dietary factors, such as flavonoid intake, are increasingly investigated for their potential role in disease prevention.
Purpose of the Study:
- To examine the association between dietary flavonoid consumption and the risk of developing neurodegenerative diseases.
- To identify specific flavonoid subclasses that may confer protective effects against NDs.
Main Methods:
- Analysis of data from 13,573 participants in the National Health and Nutrition Examination Survey (NHANES).
- Utilized weighted logistic regression, ROC curve analysis, restricted cubic splines, and subgroup analyses.
- Adjusted for various demographic, socioeconomic, lifestyle, and clinical factors.
Main Results:
- Higher total flavonoid intake was significantly associated with lower odds of NDs (Q4 vs. Q1: OR=0.52).
- Flavones (Q4 vs. Q1: OR=0.49) and flavonols (Q4 vs. Q1: OR=0.53) showed the strongest inverse associations.
- Optimal intake levels for reduced ND risk were identified: ~432 mg/day for total flavonoids, 1.7 mg/day for flavones, and 29 mg/day for flavonols.
Conclusions:
- Dietary flavonoid intake, particularly from flavones and flavonols, is inversely associated with the risk of neurodegenerative diseases.
- Moderate consumption of these specific flavonoid subclasses may contribute to neuroprotection.
- Findings suggest a potential dietary strategy for mitigating ND risk.
Related Concept Videos
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...